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Summary 
Induction of prodynorphin gene expression by psy- 
chostimulant drugs may represent a compensatory ad- 
aptation to excessive dopamine stimulation and may 
contribute to the aversive aspects of withdrawal. We 
therefore investigated the molecular mechanisms by 
which dopamine psychostimulant drugs induce prody- 
norphin gene expression in vivo and in rat primary stri- 
atal cultures. We demonstrate that three recently de- 
scribed cAMP response elements (CREs), rather than 
a previously reported noncanonical AP-1 site, are criti- 
cal for dopamine induction of the prodynorphin gene 
in striatal neurons. CRE-binding protein (CREB) binds 
to these CREs in striatal cell extracts and is phosphory- 
lated on Ser-133 after dopamine stimulation in a D1 
dopamine receptor-dependent manner. Surprisingly, 
following chronic administration of amphetamine, lev- 
els of phosphorylated CREB are increased above basal 
in rat striatum in vivo, whereas c-los mRNA is sup- 
pressed below basal levels. D1 receptor-mediated 
CREB phosphorylation appears to mediate adapta- 
tions to psychostimulant drugs in the striatum. 
Introduction 
Acute administration of the psychostimulant drugs co- 
caine and amphetamine produces euphoria in humans 
and reward in animal models (Gawin and Ellinwood, 1988; 
Gawin, 1991). Repeated administration with adequate 
dose, frequency, and chronicity can produce significant 
behavioral changes, including sensitization, tolerance, 
and dependence. Although the psychostimulants do not 
produce a physical withdrawal syndrome in humans, drug 
discontinuation following chronic administration results in 
a psychological withdrawal syndrome characterized by 
dysphoria, anhedonia, and drug craving (Gawin and Ellin- 
wood, 1988; Gawin, 1991). 
The mechanisms underlying the acute, reinforcing ac- 
tions of the psychostimulants have been shown to depend 
on potentiation of dopaminergic neurotransmission in 
mesolimbic pathways, especially projections from the ven- 
tral tegmental area to a region of the ventral striatum, the 
nucleus accumbens (Butcher et al., 1988; Di Chiara and 
Imperato, 1988a; Carboni et al., 1989; Hurd et al., 1989). 
However, the mechanisms underlying the longer-term ef- 
fects of psychostimulant administration are not yet under- 
stood. Altered release of dopamine has not been consis- 
tently observed in slices of striatum or nucleus accumbens 
derived from rats repeatedly exposed to cocaine (Kalivas 
and Duffy, 1988; Peris et al., 1990). In addition, no consis- 
tent changes have been observed in dopamine transporter 
levels or D1 dopamine receptor levels after chronic co- 
caine administration (Peris et al., 1990). The lack of consis- 
tent changes in dopamine release or in dopamine trans- 
porter or dopamine receptor protein levels following 
repeated psychostimulant administration raises the possi- 
bility that the alterations in synaptic function underlying 
drug dependence involve changes in postreceptor intra- 
cellular signaling. The requirement for repeated drug ad- 
ministration and the persistent nature of dependence sug- 
gest the involvement of drug-induced alterations in gene 
expression within critical neural circuits (Nestler, 1992; 
Nester et al., 1993; Hyman and Nestler, 1993). 
D1 dopamine receptors play a critical role in the reinforc- 
ing properties of psychostimulant drugs. Pharmacological 
studies demonstrate that pretreatment with the dopamine 
receptor antagonist SCH-23390 alters cocaine self-admin- 
istration in rat (Koob et al., 1987; Maldonado et al., 1993) 
and primate (Bergman et al., 1990). Although the SCH- 
23390 compound is selective for both D1 and D5 dopa- 
mine receptors, the lack of intrastriatal D5 dopamine re- 
ceptors (Tiberi et al., 1991) makes it likely that D1 
dopamine receptors within the striatum mediate this ef- 
fect. We hypothesize that the powerful, prolonged activa- 
tion of D1 dopamine receptor-mediated signaling pathways 
that occurs with chronic psychostimulant administration 
leads to compensatory adaptations downstream of D1 re- 
ceptors that may contribute to the drug-dependent state. 
In the dorsal and ventral striatum, the levels of dynorphin 
peptide significantly increase following repeated adminis- 
tration of the psychostimulants cocaine (Sivam, 1989; 
Smiley et al., 1990; Steiner and Gerfen, 1993) and meth- 
amphetamine (Hanson et al., 1988; Li et al., 1988). A signif- 
icant increase in prodynorphin mRNA is observed after 
rats self-administer cocaine (H urd et al., 1992), and in post- 
mortem studies of cocaine-dependent human drug abus- 
ers, there is a marked induction of prodynorphin, but not 
other peptide mRNAs, in the striatum (Hurd and Herken- 
ham, 1993). Regulation of prodynorphin gene expression 
in the striatum has been shown to be dependent upon D1 
dopamine receptor stimulation (Gerfen et al., 1990). 
Dynorphin peptides are relatively selective for the K opi- 
ate receptor and exert inhibitory actions in the nervous 
system (Chavkin et al., 1982; Corbett et al., 1982). Activa- 
tion of K receptors is associated with an aversive dysphoric 
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Figure 1. Immunohistochemical Staining of 
Primary Striatal Cultures for GFAP and NSE 
Arrow in (A) points to typical astrocyte stained 
with anti-GFAP; the surrounding smaller cells 
are counterstained. Small arrows in (B) point 
to typical neurons stained with anti-NSE; no 
counterstain was used. Bar, 20 I~m. 
syndrome in human (Pfeiffer et al., 1986) and rat (Bals- 
Kubik et al., 1993). Thus, increases in dynorphin peptides 
occurring with chronic cocaine or amphetamine use may 
potentially prove relevant to the motivational aspects of 
psychostimulant withdrawal, which in humans has been 
characterized by intense dysphoria, anhedonia, and drug 
craving (Gawin, 1991). We therefore performed a series 
of experiments to investigate the molecular mechanisms 
by which D1 dopamine receptor activation might be cou- 
pled to regulation of the prodynorphin gene. 
The mechanisms by which the prodynorphin gene is 
regulated by Gs-coupled receptors and cyclic AMP (cAM P) 
are controversial. Until recently, studies assessing dynor- 
phin gene regulation have focused on a noncanonical acti- 
vating protein 1 (AP-1)-Iike site (TGACAAACA; -257/ 
-249) in the prodynorphin promoter. This site has been 
reported to serve as a target for Fos/Jun trans-activation 
in NCB20 neuroblastoma cells (Naranjo et al., 1991). 
Moreover, c-Fos has been reported to be required for 
cAMP-mediated prodynorphin gene induction in spinal 
cord neurons (Lucas et al., 1993). 
Recently, the prodynorphin promoter has been shown 
to contain three elements within its 5' flanking sequences 
that are homologous to the consensus cAMP response 
element (CRE), termed DynCRE1 (-1660/-1553), Dyn- 
CRE2 (-1630/-1623), and DynCRE3 (-1546/-1539). 
These three elements have been characterized by dele- 
tion and single-base mutagenesis and are required for the 
positive regulation of the prodynorphin gene via cAMP 
pathways in CV-1 fibroblasts (Douglass et al., 1994). In 
addition, it has been demonstrated that DynCRE3 is in- 
volved in cAMP responsiveness of the prodynorphin gene 
in PC12 cells (Messersmith et al., 1994). Although these 
CREs have been shown to be functional in cell lines, a 
disagreement exists as to the relevant proteins binding 
these elements in vivo. A recent study found that purified 
CRE-binding protein (CREB), purified Jun protein, and pu- 
rified Fos/Jun heterodimers can all bind with high affinity 
to DynCRE3 (Collins-Hicok et al., 1994). This study also 
reported that in unstimulated CV-1 fibroblasts CREB co- 
transfected with the rat prodynorphin gene acted as a re- 
presser, whereas the cotransfected AP-1 proteins, Fos 
and Jun, were activators (Collins-Hicok et al., 1994). 
As a first step in understanding the relevant signal trans- 
duction pathways regulating prodynorphin in response to 
psychostimulants and dopamine, it was necessary to de- 
termine which proteins actually interact with the prodynor- 
phin gene in the relevant neurons. We report that the Dyn- 
CRE1, DynCRE2, and DynCRE3 elements are required 
for full activation of the prodynorphin promoter in response 
to dopamine in striatal neurons and demonstrate that the 
AP-1 element, by itself, does not confer significant activa- 
tion. In addition, we find that the induction of the prodynor- 
phin gene by cAMP does not require new protein synthe- 
sis. We demonstrate that CREB binds to the DynCREs in 
extracts from striatal cultures, and that CREB, in a form 
that can bind the prodynorphin CREs, is phosphorylated 
in response to dopamine in a D1 dopamine receptor- 
dependent manner. We do not observe significant protein 
binding to the putative noncanonical AP-l-like site in our 
extracts, even under conditions that produce robust AP-1 
binding to a consensus AP-1 sequence. Our data indicate 
that CREB but not AP-1 proteins serve to couple D1 dopa- 
mine receptor stimulation to prodynorphin gene expres- 
sion in striatal neurons. We have previously shown that 
acute amphetamine administration induces CREB phos- 
phorylation in Striatum in vivo, and that CREB is required 
for amphetamine-induced c-fos gene expression (Konradi 
et al, 1994). Here we show that chronic amphetamine ad- 
ministration elevates levels of phosphoCREB immunore- 
activity above basal levels, but suppresses c-fos mRNA 
expression below basal levels, demonstrating a dissocia- 
tion between CREB phosphorylation and c-fos expression 
in the chronic state. Chronic elevation in levels of phos- 
phorylated CREB is a potential mechanism for stimulant- 
induced adaptations in rat striatum. 
Results 
Dopamine Markedly Induces cAMP Levels and 
c-los mRNA in Cultured Striatal Neurons 
To elucidate the mechanisms of prodynorphin gene ex- 
pression by dopamine in striatal neurons, we utilized neu- 
ron-enriched E19 rat embryonic primary striatal cultures. 
Immunohistochemical staining of the cultures with an anti- 
serum directed against glial fibrillary acidic protein (GFAP) 
shows a large GFAP-positive astrocyte (Figure 1A) sur- 
rounded by smaller GFAP-negative cells, which are 
counterstained. Across multiple fields, the ratio of GFAP- 
negative cells to astrocytes is greater than 10:1. Histo- 
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Figure 2. Dopamine Stimulation Increases cAMP Levels and Induces 
Expression of c-fos mRNA in Primary Striatal Cultures 
(A) Time course showing a 30- to 40-fold increase in cAMP levels 10
min after treatment with dopamine (50 p.M) and Ro20-1724 (50 p_M; 
open squares); Ro20-1724 alone (open diamonds) had no independent 
effects on cAMP levels (n = 3). 
(B) Northern analysis with c-fos riboprobe showing a 10- to 30-fotd 
increase in c-fos mRNA 45 min after stimulation by dopamine/Ro20- 
1724. Induction was blocked by 10 min pretreatment with the D1 dopa- 
mine receptor antagonist SCH-23390 (100 ,M). SCH-23390 alone and 
Ro20-1724 alone had no independent effects on c-fos mRNA expres- 
sion. Ribosomal RNA (28S) was used as an internal loading control 
(1 #g RNA per lane; n = 4). 
chemical staining in a parallel culture with an antiserum 
directed against neuron-specific enolase (NSE) demon- 
strates that a large percentage of the small GFAP-negative 
cells in Figure 1A are neurons (Figure 1 B; no counterstain). 
A subpopulation of cells did not stain with either antiserum; 
overall, we estimate the striatal cultures to be greater than 
80% neuronal. 
In culture, it is not possible to use indirect dopamine 
agonists such as amphetamine or cocaine as a stimulus 
because their effects on doparnine concentrations require 
presynaptic innervation. Therefore, in our experiments we 
used dopamine itself. The D1 dopamine receptor, which 
is positively linked to adenylate cyclase, is required for 
psychostimulant induction of c-fos gene expression (Gray- 
biel et al., 1990; Young et al., 1991; Nguyen et al., 1992) 
and CREB phosphorylation (Konradi et al., 1994) in stria- 
turn in vivo. To test for the intactness of the D1 dopamine 
receptor signaling pathway in our cultured neurons, we 
performed a time course of dopamine treatment and mea- 
sured cAMP levels. Stimulation with dopamine and the 
phosphodiesterase inhibitor Ro20-1724 resulted in a 40- 
fold increase in cAMP levels, which was observable 5 min 
after treatment, peaked at 10-15 min, and was down to 
10-fold after 1 hr (Figure 2A). In response to forskolin, 
the direct activator of adenylate cyclase, a greater than 
100-fold increase in cAMP levels was observed, which 
peaked 10 min after treatment (data not shown). In addi- 
tion, we observed a 10- to 30-fold induction of c-fos mRNA 
after dopaminergic stimulation (Figure 2B, lanes 5 and 6). 
This induction of c-fos was blocked by pretreatment with 
the D1 dopamine receptor antagonist SCH-23390 (Figure 
2B, lanes 7 and 8). To rule out the possibility that glial 
cells contributed to the observed response, we compared 
the neuron-enriched cultures with glial-enriched cultures 
that were grown in parallel. The glial-enriched cultures, 
produced by mechanically shaking off the neurons, 
showed a 1.5-fold induction of c-fos by dopamine (data 
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Figure 3. Prodynorphin mRNA Is Induced by the cAMP Pathway in 
Primary Striatal Cultures in a Protein Synthesis-Independent Manner 
(A) Northern analysis with a prodynorphin riboprobe showing prody- 
norphin mRNA induced 2- to 3-fold 6 hr after dopamine/Ro20-1724 
treatment. 
(B) The 5- to 7-fold induction ofprodynorphin mRNA 6 hr after stimula- 
tion by forskolin, a more potent stimulator of cAMP pathways, and 
Ro20-1724 (F/Ro) was not blocked by 15 min pretreatrnent with the 
protein synthesis inhibitors cycloheximide (Cyclo; 100 p.M) or aniso- 
rnycin (Aniso; 10 ~M), indicating protein synthesis independence. Two 
different protein synthesis inhibitors were used to control for nonspe- 
cific pharmacological effects. Ro20-1724 (Ro) alone had no effect on 
prodynorphin mRNA levels. Control cultures received no drug treat- 
ment. Ribosomal RNA (18S) was used as an internal loading control 
(2-3 ~g of RNAwas loaded per lane). All results were replicated at least 
four times. In (A) only, the antioxidant sodium metabisulfite (0.010/o; 
Sigma), which has no independent effects (data not shown), was in- 
cluded in the drug treatment. 
not shown), compared with the 10- to 30-fold induction 
observed in the neuron-enriched cultures. 
Prodynorphin mRNA Is Induced in Primary 
Striatal Cultures by cAMP in a Protein 
Synthesis-Independent Manner 
Northern analysis was used to confirm that prodynorphin 
mRNA is present in our striatal cultures. Prodynorphin 
mRNA levels were very low basally in the cultures and 
were induced 2- to 3-fold after acute stimulation by dopa- 
mine (Figure 3A). As the D1 dopamine receptor is posi- 
tively coupled to adenylyl cyclase, we also utilized for- 
skolin, a more potent stimulus than dopamine, mn response 
to forskolin, a 5- to 7-fold induction of prodynorphin mRNA 
was observed (Figure 3B). Since prodynorphin mRNA is 
not present in gila, as determined by Northern analysis 
performed on glial-enriched cultures(data not shown), the 
forskolin effect is likely entirely neuronal. 
To begin to investigate the mechanism of prodynorphin 
induction by cAMP in striatal neurons, we used short-term 
treatment with protein synthesis inhibitors. The effects of 
longer-term protein synthesis inhibition are not informa- 
tive, owing to toxicity and the variable turnover time of 
critical signal transduction proteins. However, the rela- 
tively small inductions of prodynorphin mRNA observed 
in response to short-term dopamine treatment make any 
potential inhibitory effects of protein synthesis inhibitors 
difficult to assess. The larger forskolin-induced increase 
in prodynorphin mRNA levels was not inhibited by either 
of the protein synthesis inhibitors, cycloheximide and ani- 
somycin (Figure 3B). Induction of prodynorphin mRNA in- 
dependently of new protein synthesis is consistent with 
the hypothesis that constitutively expressed transcription 
factors are involved in the observed regulation. 
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Figure 4. Dopamine Stimulation Activates Ex- 
pression of a Prodynorphin-CAT Fusion Con- 
struct 
(A) The prodynorphin promoter showing the 
three 5' DynCRE elements and the noncanoni= 
cal AP-1 element. The CAT fusion constructs 
used in transfection experiments are shown in 
the lower portion of (A). The full-length 2 kb 
construct contains all three DynCRE sites and 
the putative noncanonical DynAP-1 site. In the 
1.7 kb construct, he two 5' CREs are deleted. 
In the 1.6 kb construct, only the putative AP-1 
element is preserved. 
(B) After transfection with the 2 kb prodynor- 
phin-CAT construct, an 8-to 10-fold increase 
in CAT activity followed stimulation with dopa- 
mine and Ro20-1724 (DNRo) as compared 
with control or Ro20-1724 alone (n/> 4 for each 
drug condition). 
(C) Comparison of the induction of the 2 kb 
prodynorphin-CAT construct and the 1.7 and 
1.6 kb constructs, which lack either two or all 
three of the DynCREs. In cells transfected with 
the 1.7 and 1.6 kb constructs, dopamine/Ro20- 
1724 treatment o longer produced significant 
induction. Background CAT activity deter- 
mined from untransfected controls has been 
subtracted from the values hown. Data in (B) 
and (C) -+ SEM. 
Three CREs in the Prodynorphin Promoter Are 
Required for cAMP Responsiveness 
To ensure that the observed regulation has a transcrip- 
tional component and to determine whether the three 
CREs previously shown to be functional in transformed 
fibroblast cell lines are also functional in striatal neurons, 
we performed transfection studies in primary striatal cul- 
tures. Transfection with a construct containing the three 
upstream prodynorphin CREs as well as the putative non- 
canonical prodynorphin AP-1 element (Naranjo et al., 
1991) fused to the CAT gene (2 kb; -1858/+135; Figure 
4A) resulted in a 7- to 10-fold increase in CAT activity 
after dopamine stimulation (Figure 4B). Transfection with 
constructs containing deletions of the two 5' DynCREs (1.7 
kb; -1602/+135) or of all three DynCREs (1.6 kb; -1500/ 
+135), but still containing the prodynorphin AP-l-like ele- 
ment, showed a dramatic reduction in CAT activity (Figure 
4(3). Parallel transfections were performed in glial-enriched 
cultures, and no dopamine response was detectable, indi- 
cating that the reported effects are likely neuronal. 
A fine-grained promoter analysis could not be performed 
in our primary neuronal cultures because partial inactiva- 
tion of the promoter produces expression that is very near 
the limits of reliable detection (Figure 4C). Thus, the rela- 
tive contribution of each of the individual CREs in prody- 
norphin gene regulation cannot be readily assessed in 
striatal neurons. However, our results agree entirely with 
those obtained in CV-1 fibroblasts (Douglass et al., 1994), 
i.e., that these three upstream DynCRE elements are re- 
quired for significant induction of the prodynorphin gene 
in response to stimuli that act via the cAMP pathway. Fine 
mapping in CV-1 cells has demonstrated that each of the 
DynCREs is functional, and that they act combinatorially to
produce full transcriptional effects (Douglass et al., 1994). 
Gel-Shift Competition Assays Demonstrate a 
CREB-Like Protein Binding to the Prodynorphin 
CREs and a Lack of Binding to the Putative 
Noncanonical Prodynorphin AP-1 Element in 
Extracts from Primary Striatal Cultures 
To investigate the proteins that bind to the DynCREs in 
extracts from striatal neurons, we performed gel-shift 
assays using oligonucleotides containing single DynCREs 
together with cell extracts from primary striatal cultures. 
The specificity of complexes formed with the DynCRE ele- 
ments and the relative affinities of bound proteins for the 
DynCREs compared with consensus regulatory elements 
were examined using cold competition. Complexes 
formed with striatal extracts were assessed using each of 
the three DynCREs (DynCRE3 is shown; Figure 5A), a 
consensus palindromic CREB/activating transcription fac- 
tor (ATF) DNA binding site (Hal et al., 1989; Figure 5B), 
a consensus AP-1 element (Figure 5C), and the putative 
noncanonical prodynorphin AP-l-like element (Figure 5D). 
Cold competition was performed with oligonucleotides 
containing the ATF and consensus AP-1 elements and, 
for comparison, an unrelated AP-4 element. 
In extracts from primary striatal cultures, the oligonucle- 
otides containing the DynCRE elements (DynCRE3 is 
shown; Figure 5A) and the CREB/ATF element (Figure 
5B) showed very similar patterns of binding and competi- 
tion. In both cases, the ATF oligonucleotide competed 
strongly for protein binding, whereas an oligonucleotide 
containing the closely related consensus AP-1 site com- 
peted far less avidly (Figures 5A and 5B). An oligonucleo- 
tide containing an unrelated AP-4 site did not compete for 
binding with either labeled oligonucleotide. There was no 
quantitative change in binding to the DynCRE3 or ATF 
oligonucleotides following a 2 hr forskolin/Ro20-1724 
CREB Regulation of Prodynorphin in Rat Striatum 
817 
A DynCRE3 B ATF 
AP-1 ATF ~ AP-1 ATF ~ AP-1 ATF ~ AP-1 ATF 
I II I~  I II I~>< ~.1 II I X I II I X 
~ ~ ~ =  ~ o × ×o~ × ×o Z o Z oo  Z o~< c~o 
--  specific 
band 
- -  free 
t 11 I probe [ 1 [ 
Unstimulated Forskolin/Ro Unstimulated Forskolin/Ro 
C SP AP-1 D Dyn AP-1 like 
AP-1 ATF ~ AP-1 ATF ~ AP-1 ATF ~ AP-1 ATF 
I II I),< I II I )<  I I1 l X [ II I x 
° × X°~x Xx  x~ ~×oxoo x ox  oo  X o X ~ X X o ~ X M c~ 
-- specific 
band 
--  free 
l probe 
- -  free -- free 
I i l I probe [ ] I I probe 
Unstimulated Forskolin/Ro Unstimulated Forskolin/Ro 
Figure 5. Electrophoretic Mobility Shift Assay 
with Extracts from Primary Striatal Cultures 
The specificity of binding and the relative affini- 
ties of the complexes for consensus AP-1 and 
CREB binding sites were examined using cold 
competition. Binding tothe DynCRE3 site (A), 
a consensus CREB binding site (B; ATF), a con- 
sensus AP-1 binding site derived from the sub- 
stance P promoter (C; SP AP-1), and the puta- 
tive noncanonical prodynorphin AP-1 element 
(D; Dyn AP-1 like) is shown. Specifically shifted 
bands were formed by striatal extracts with the 
DynCRE3, ATF, and SP AP-1 elements (A-C), 
but not with the noncanonical AP-1 element 
(D). When complexes were formed with the 
DynCRE3, ATF, and SP AP-1 elements with 
extracts from unstimulated cultures (no drug 
treatment), basal binding (left-most lane 
marked Con [no competitor]) in (A), (B), and (C) 
was observed. In each of these cases, unla- 
beled oligonucleotides containing the ATF ele- 
ment competed strongly for proteins bound to 
labeled oligonucleotide. In extracts made after 
2 hr stimulation with forskolin/Ro20-1724, bind- 
ing was markedly induced only with the SP 
AP-1 oligonucleotide (C; compare binding in 
the unstimulated and stimulated Con lanes). 
Stimulation also altered the pattern of competi- 
tion to SP AP-1 by unlabeled oligonucleotides, 
such that the ATF oligonucleotide no longer 
fully competed. This is consistent with the ob- 
servation that AP-1 proteins are induced. In
contrast, stimulation with forskolin/Ro did not 
substantially alter binding to the DynCRE3 ele- 
ment or the ATF element (A and B) either quan- 
titatively (Con lanes) or in terms of pattern of
competition. In all cases, the unrelated AP-4 
element did not compete for binding even at 
100-fold molar excess. The numbers at the top 
signify molar excess ofcold competitor oligonucleotides. Note that the competitions with the AP-1 oligonucleotide in (C) and the ATF oligonucleotide 
in (B) sites are self-competitions. All experiments were performed in probe excess. Ea h experiment was repeated at least four times. 
treatment (Figures 5A and 5B, control), a time at which 
Fos and other AP-1 proteins were markedly induced in 
these cells (Figure 5C; compare unstimulated and for- 
skolin/Ro). These results indicate that the specific band 
represents binding of a protein(s) with higher affinity for 
CREB/ATF binding sites than for AP-1 binding sites. Dyn- 
CRE1 and DynCRE2 show a binding pattern essentially 
identical to DynCRE3 and ATF (data not shown). 
in untreated striatal cultures, cold oligonucleotides con- 
taining an ATF element effectively competed for binding 
of proteins to oligonucleotides containing the AP-1 ele- 
ments of the preprotachykinin (substance P; Figure 5C) 
and human metallothionein genes (data not shown), likely 
indicating that, in the unstimulated cultures, constitutively 
expressed CREB-like proteins are abundant enough com- 
pared with inducible AP-1 proteins that they comprise most 
of the protein interacting with AP-1 sites. However, 2 hr 
after stimulation with forskolin/R020-1724, binding to the 
AP-1 oligonucleotide was induced (Figure 5C; compare 
control lanes). Moreover, the ATF competitor oligonucleo- 
tide could no longer fully compete, consistent with induc- 
tion of AP-1 proteins by cAMP. Nonetheless, 2 hr after 
forskolin/Ro20-1724 treatment, when binding to the con- 
sensus AP-1 element is induced, no specific binding to 
the putative noncanonical prodynorphin A P-1 element 
(Naranjo et al., 1991) was detectable (Figure SD). 
Gel Supershift Analysis Shows CREB Binding 
to the Three Prodynorphin CREs and CREB 
Phosphorylation after Treatment 
with Dopamine or Forskolin 
We used antisera recognizing total CREB protein and 
CREB only when phosphorylated on Ser-133 (phospho- 
CREB; Ginty et al,, 1993) to investigate the composition 
of the specific complexes observed in the electrophoretic 
mobility shift assays. As shown for the three prodynorphin 
CRE sites, the specific band is entirely supershifted by a 
CREB antiserum (Figures 6A-6C, lanes 4-6), indicating 
that CREB proteins bind these elements in striatal ex- 
tracts. Whether the complex contains a CREB homodimer 
or whether CREB is heterodimerizing with another protein 
requires further analysis. Recognition of the binding com- 
plex by the CREB antiserum is consistent with the more 
avid competition of cold CREB/ATF oligonucleotides than 
of cold AP-1 oligonucleotides for the proteins bound to the 
DynCREs (Figures 5A-5C) .  
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Figure 6. Supershift Analysis Demonstrating 
that CREB Binds to the Three Prodynorphin 
CRE Elements and Is Phosphorylated after 
cAMP Pathway Activation 
(A-C) Binding to the DynCRE site was not 
quantitatively altered in extracts from un- 
treated primary striatal cultures compared with 
extracts from cultures treated for 15 min with 
dopamine/Ro20-1724 (Da/Ro) or forskolin/ 
IBMX (F/I; [A]-[C], lanes 1-3). In the presence 
of a CREB antiserum, the band, which was 
shown to be specific by cold competition (Fig- 
ure 5A), is entirely supershifted (A-C, lanes 4- 
6). A nonspecific band produced by serum 
components is present only in these three 
lanes and is also present if preimmune serum 
is used (data not shown). In the presence of 
the antiserum that only recognizes the phos- 
phorylated form of CREB (phosphoCREBa), a
supershifted band appeared only after drug 
stimulation (A-C; compare lane 7 with lanes 8 
and 9;n = 4). 
(D) As shown for DynCRE3, the phosphoryla- 
tion of CREB after stimulation with dopamine 
and Ro20-1724 was blocked by 15 min pretreat- 
ment with the D1 dopamine receptor antagonist 
SCH-23390. Ro20-1724 and SCH-23390 alone 
had no effects on CREB phosphorylation. Each 
experiment was repeated at least four times. 
As CREB binds to the three prodynorphin CRE ele- 
ments, we next investigated whether CREB is phosphory- 
lated on Ser-133 after dopamine or forskolin stimulation. 
Using a phosphoCREB antiserum (Ginty et al., 1993), we 
observed induction of a supershifted band in response to 
stimulation of cells with dopam ine/R020-1724 or forskolin/ 
3-isobutyl-l-methylxanthine (IBMX; Figures 6A-6C, com- 
pare lane 7 with lanes 8 and 9). In response to dopamine 
and forskolin, the supershift is partial. However, in cultures 
stimulated in the presence of the phosphatase inhibitor 
okadaic acid (1 p.M; GIBCO-BRL, Gaithersburg, MD), a 
nearly complete supershift was observed (data not 
shown). These results indicate that the three DynCRE 
sites bind CREB in extracts from primary striatal cultures 
and that CREB is phosphorylated inresponse to dopamine 
treatment. 
k 
Phosphorylation of CREB in Response to Dopamine 
Is Rapid and Dependent upon D1 Dopamine 
Receptor Activation • 
The induction of the phosphoCREB supershifted band by 
dopamine was blocked by pretreatment with SCH-23390 
(Figure 6D), indicating that the phosphorylation of CREB 
in response to dopamine treatment is dependent upon 
D1 dopamine receptor activation. Pretreatment with the 
selective D2 dopamine receptor antagonist eticlopride (50 
I~M) had no effect on dopamine-induced CREB phosphory- 
lation (data not shown). The selective D1 dopamine recep- 
tor agonists SKF-82938 (50 ~M) and SKF-38393 (50 ~M) 
both induced CREB phosphorylation, and this effect was 
not altered by eticlopride (50 ~M) pretreatment. The D2/ 
D3 dopamine receptor agonist quinpirole (50 I~M) did not 
induce CREB phosphorylation in the cultures (data not 
shown). Together, these data indicate that D1 but not D2 
family dopamine receptors are required for CREB phos- 
phorylation in striatal culture. 
A time course using electrophoretic mobility shift assays 
demonstrates that total CREB binding to the DynCRE ele- 
ments is not quantitatively altered after dopamine stimula- 
tion (Figure 7A; DynCRE1 shown). However, utilizing the 
phosphoCREB antiserum, we show that CREB phosphor- 
ylation is apparent at 5 min, peaks at 15-30 min, and 
returns to baseline at 3 hr after dopamine stimulation (Fig- 
ure 7B). This time course of CREB phosphorylation closely 
correlates with the time course of cAMP induction in re- 
sponse to dopamine (compare Figure 2). A similar time 
course of phosphorylation was observed using oligonucle- 
otides containing the DynCRE2 and DynCRE3 elements 
(data not shown). 
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phosphoCREBcz 
Figure 7. Time Course Showing Dopamine In-
duction of Phosphorylated CREB in a Form 
That Can Bind DNA in Primary Striatal Cultures 
(A) CREB binding was not quantitatively al- 
tered after stimulation of cultures with dopa- 
mine and Ro20-1724. 
(B) In the presence of the phosphoCREB anti- 
serum, a phosphoCREB supershifted band 
was present 5 rain after dopaminergic stimula- 
tion, peaked at 15 rain, and was back to base- 
line levels by 3 hr. DynCRE1 is shown; compa- 
rable results were obtained with DynCRE2 and 
DynCRE3. Each experiment was repeated at 
least three times. 
Following Chronic Amphetamine Administration, 
PhosphoCREB-Like Immunoreactivity Is 
Elevated and c-fos mRNA Is Suppressed 
in Rat Striatum 
There are low basal level of phosphoCREB-l ike immunore- 
activity (phosphoCREB-LI) in saline control rat striatum 
(Figure 8A). PhosphoCREB-LI was markedly induced, 
however, by acute amphetamine administration (Figure 
8B). When chronically treated rats were given a final am- 
phetamine injection 15 min prior to sacrifice (chronic/acute 
condition; see Experimental Procedures), phosphoCREB- 
LI was significantly increased above control levels, but 
was less than that in acutely treated rats (data not shown). 
When the last amphetamine injection was replaced by sa- 
line (chronic condition; see Experimental Procedures), 
meaning that the rats were sacrificed 16 hr after the final 
injection of active drug, phosphoCREB-LI in the striatum 
was significantly increased over saline controls (Figure 
8C), although not quite to the same extent as when a final 
amphetamine injection was administered. This increase 
in phosphoCREB-LI was observed even if no final saline 
injection was administered (data not shown), ruling out 
the possibility that this represents a conditioned response. 
This is in agreement with the demonstration that, following 
exposure to a cocaine paired environment, conditional 
neuronal activation does not occur in the dorsal striatum 
or nucleus accumbens (Brown et al., 1992). Levels of total 
CREB-LI are not altered by the different drug treatments 
(data not shown). 
Basal levels of c-fos mRNA are low in control rat striatum 
Figure 8. PhosphoCREB-Like Immunoreactivity after Acute and 
Chronic Amphetamine Administration in Rat Striatum 
(A) Basal levels of phosphoCREB-LI in unstirnulated rat striatum are low. 
(B) PhosphoCREB-LI was induced by acute amphetamine (6 mg/kg) 
administration. 
(C) After chronic amphetamine administration, phosphoCREB-LI was 
significantly increased over unstimulated controls. ANOVA found a 
significant difference between the three groups (F(2,8) = 38.1; p = 
.0004). Post-hoc Fisher LSD tests found that both the chronic and 
acute treatment groups were significantly different from the control 
group (p < .05). Significance was also obtained with the nonparametric 
Kruskal-Wallis test (H = 7.2; p =..02), followed by the Mann-Whitney 
U test to compare drug treatment groups with control (Z = 1.96; p = 
.04). Bar, 100 ~.m. 
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Figure 9. Northern Blot Analysis Showing c-fos mRNA Regulation by 
Acute and Chronic Amphetamine Administration 
c-fos mRNA was induced in rat striatum following acute amphetamine 
(6 mg/kg) administration and was suppressed below basal levels fol- 
lowing chronic drug administration in rat striatum. Cyclophilin mRNA 
was used as an internal loading control (8 p,g of total striatal RNA per 
lane; n = 6 per treatment group). 
and could be robustly induced by acute amphetamine ad- 
ministration (Figure 9). Following chronic amphetamine 
treatment, c-fos mRNA was reproducibly suppressed be- 
low basal levels of expression, demonstrating a dissocia- 
tion between c-fos mRNA levels and phosphoCREB-LI 
after chronic amphetamine administration. 
Discussion 
It has been well documented that the indirect dopamine 
agonists cocaine and amphetamine produce a selective 
increase in prodynorphin mRNA levels in dorsal and ven- 
tral striatum. As a model to investigate psychostimulant- 
mediated signal transduction, we have utilized rat primary 
embryonic striatal cultures to examine prodynorphin gene 
regulation by dopamine. We find, consistent with prior 
transfection studies examining cAMP regulation in CV-1 
fibroblasts and PC-12 cells (Douglass et al., 1994; Messer- 
smith et al., 1994), that the three upstream CREs within 
the prodynorphin promoter are necessary for full induction 
by dopamine in striatal neurons. Using gel-shift and su- 
pershift analyses, we find that CREB protein binds to these 
three functional CRE sites in striatal cell extracts and is 
phosphorylated after dopamine treatment in a D1 dopa- 
mine receptor-dependent manner. We do not observe 
binding in striatal cell extracts to the putative noncanonical 
AP-1 site (Naranjo et al., 1991), even under assay condi- 
tions that detect inducible binding to a consensus AP-1 
site. It was recently demonstrated by cotransfection analy- 
sis in CV-1 cells that purified CREB, purified Jun protein, 
and purified Fos/Jun protein also do not bind this element 
(Collins-Hicok et al., 1994). 
Our data are consistent with the hypothesis that CREB 
binds the three functional upstream CREs under both 
basal and stimulated conditions and is activated by phos- 
phorylation. This is entirely congruent with models of 
CREB function in cell lines (Gonzalez and Montminy, 
1989). It is therefore important to address a recent study 
reporting that CREB represses expression of a prodynor- 
phin fusion construct when the two are cotransfected into 
unstimulated CV-1 fibroblasts (Collins-Hicok et al., 1994). 
In cotransfection studies, large amounts of the transcrip- 
tion factor, in this case CREB, are produced under the 
control of a strong, constitutively active promoter. Under 
such conditions, a large excess of unphosphorylated 
CREB may dimerize with basally phosphorylated CREB 
in the nucleus, or may similarly titrate out other necessary 
transcription factors. The physiological significance of re- 
pression under these conditions is challenging to sort out; 
cotransfection studies provide data on the range of possi- 
ble interactions of transcription factors with targets, but 
cannot specify what actually occurs under more physiolog- 
ical conditions. 
It is not surprising that both purified AP-1 proteins and 
CREB have been reported to bind the prodynorphin CREs 
in vitro (Collins-Hicok et al., 1994), as consensus AP-1 
sites and CREB binding sites differ by only a single base 
(TGAC/GTCA versus TGACGTCA). The prodynorphin 
CREs are asymmetric CREs intermediate between con- 
sensus AP-1 and CREB binding sites. It should be noted, 
however, that they all contain the CGTCA core that has 
been shown to be relatively rigidly required for cAMP acti- 
vation (Hyman et al., 1988), but not for AP-1 protein bind- 
ing. Thus, for example, in the proenkephalin CRE2 site, 
which is identical to DynCRE3, a single base substitu- 
tion mutation that converts the site from a CRE site 
(TGCGTCA) to a consensus AP-1 site (TGAGTCA) gives 
high affinity binding of purified AP-1 proteins, but is func- 
tionally unresponsive to cAMP (Comb et al., 1988). 
Our results demonstrate that, in the complex mix of a 
striatal cell extract, it is CREB rather than AP-1 proteins 
that bind to all three DynCREs, even under conditions 
that induce c-Fos. We conclude that, even though AP-1 
proteins can bind the prodynorphin CRE sites in vitro (Col- 
lins-Hicok et al., 1994), in striatal neurons it is likely that 
CREB-like proteins actually interact with the gene. The 
probable role of CREB-like proteins rather than inducible 
AP-1 proteins, such as c-Fos and c-Jun, in cAMP induction 
of prodynorphin gene expression is underscored by our 
finding that the induction occurs independently of new 
protein synthesis. 
Rats chronically treated with amphetamine show in- 
creased phosphoCREB-like immunoreactivity 16 hr after 
the final amphetamine injection. This result indicates that, 
although in cultured cells CREB phosphorylation and de- 
phosphorylation occur rapidly (Figure 7B), a moderate in- 
crease in steady-state phosphoCREB-LI is present in the 
striatum of rats chronically treated with amphetamine, 
even at a time at which c-fos mRNA is reduced below 
basal levels. Suppression of zif268 and c-fos m RNA levels 
below basal following chronic cocaine treatment has pre- 
viously been demonstrated (Bhat et al., 1992; Ennulat and 
Cohen, 1995). This dissociation is also consistent with a 
role for CREB in mediating the increases in prodynorphin 
mRNA observed chronically. The chronic elevated levels 
of phosphoCREB-LI are also consistent with the up- 
regulation of cAMP pathways that occurs in vivo following 
chronic cocaine administration (Terwilliger et al., 1991). 
In the striatum, there is evidence that dynorphin, re- 
leased by recurrent collaterals, acts to control the re- 
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sponse  of  str iatal neurons  to dopaminerg ic  st imulat ion 
(Steiner and Gerfen,  1993). In addit ion, K opio id receptor  
agonists  a t tenuate  the acute motor  st imulatory ef fects and 
the s tereotypy produced by coca ine  administrat ion,  as well 
as coca ine- induced behaviora l  sensi t izat ion in the rat 
(He idbreder  et al., 1993). These  prior s tud ies  suggest  that 
dynorph in  pept ides,  acting v ia K opiate receptors,  may 
negat ive ly  modu la te  cel lular responses  to dopaminerg ic  
st imulat ion.  
K receptor  b inding is present  th roughout  the dorsal  and 
ventral  str iatum (Tempel  and Zukin, 1987; Mansour  et al., 
1987), but the precise locat ion at which dynorph in  pep- 
t ides act remains  unclear.  The  substant ia  nigra pars com- 
pacta  expresses  high levels of  1< receptor  mRNA,  yet 
shows  very little • receptor  binding,  suggest ing  that the 
nigral  K receptors  are t ranspor ted  to presynapt ic  termi- 
nals in the striatu m (Mansour  et al., 1994). Dynorph in  pep- 
t ides can potent ly  and select ively  inhibit the re lease of  
dopamine  in s l ices from rat str iatum (Mulder  et al., 1984). 
In v ivo microdia lys is  studies a lso demonst ra te  that dynor-  
phin ana logs  and/or  K op iate  receptor  agonis ts  inhibit 
dopamine  re lease within the str iatum and nucleus accum- 
bens  (Di Ch iara  and Imperato,  1988b; Spanage l  et al., 
1990). 
Select ive changes  in dynorph in  pept ide levels after  re- 
peated psychost imulant  administrat ion may represent  a 
compensatory  inhibitory response  to excess ive  st imula- 
t ion mediated via D1 dopamine  receptors.  When un- 
masked by drug d iscont inuat ion,  s t imulant - induced in- 
c reases  in dynorph in  may contr ibute to the motivat ional  
aspects  of psychost imulant  withdrawal ,  character i zed  in 
humans  by intense dysphor ia ,  anhedonia ,  and drug crav- 
ing (Gawin, 1991). Here we have invest igated the mecha-  
nism by which psychost imulant  drugs may produce  these 
compensatory  adaptat ions.  
Experimental Procedures 
Animals and Drug Paradigm 
Male Sprague-Dawley rats (200-250 g) were housed three per cage 
and maintained on a 12/12 hr light/dark cycle. Amphetamine sulfate 
(Research Biochemicals Inc., Natick, MA) was dissolved in saline and 
administered (6 mg/kg, free base) intraperitoneally. The experiments 
involve four groups of rats: control, acute, chronic, and chronic/acute. 
The control rats receive saline injections twice a day, 7 hr apart (10: 
00 AM and 5:00 PM), for 6 days and a single saline injection on day 
7. For the acute amphetamine paradigm, saline was administered for 
6 days, and a single amphetamine injection was administered on day 
7. In the chronic paradigm, rats were administered am phetamine twice 
daily for 6 days and given a single saline injection, or no final injection, 
on day 7. Therefore, the chronic rats are sacrificed 16-18 hr after their 
last amphetamine injection. In the chronic/acute condition, amphet- 
amine was administered twice daily for 6 days, and a final amphet- 
amine injection was given on day 7. For phosphoCREB and CREB 
immunohistochemistry, rats were perfused 15 rain after the last injec- 
tion on day 7. For Northern analysis, rats were perfused 45 min after 
the final injection. 
Primary Striatal Cultures 
Striata were dissected out under a stereo-microscope from 19-day-old 
Sprague-Dawley rat fetuses. Tissue was suspended in 2 ml of media 
(DMEM/F12 from GIBCO-BRL) with the following supplements: 4.5 
g/I glucose, lO/o penicillin-streptomycin liquid (GIBCO), and 10% Nu- 
serum I (Collaborative Biomedical Products, Bedford, MA) with 0.2% 
DNase. The tissue was mechanically dissociated with a fire-narrowed 
Pasteur pipette, centrifuged, resuspended in media, and plated in 
6-well plates (Costar, Cambridge, MA) at 2 x 106 cells per well. Plates 
were pretreated with a 1:500 diluted solution of polyethylenimine in 
50 mM sodium borate (pH 7.4) for 24 hr and washed twice with PBS 
prior to plating. On day 2 in culture, cells were refed with defined media 
containing B27 supplement (GIBCO) to inhibit glial proliferation. 
Experiments were performed with cells 6-8 days in culture. Drugs 
for treatment of cultures included dopamine (50 p.M) or forskolin (10 
p.M) with a selective inhibitor of cAM P phosphodiesterase: Ro20-1724 
(50 pM; RBI, Natick, MA) or IBMX (500 p.M; Sigma, St. Louis, MO) 
and SCH-23390 (100 I~M; RBI), a selective antagonist at dopamine 
D1 and D5 (also called Dla and Dlb) receptors, cAMP levels were 
determined using a cAMP [3H] assay system (Amersham, Arlington 
Heights, IL) according to the provided protocol. 
Northern Blot Analysis 
Striatal cultures were washed once with PBS on ice, scraped into a 
microcentrifuge tube, and centrifuged at 4°C for 3 rain at 14,000 rpm. 
The supernatant was aspirated and the cells lysed in 500 p.I of Nonidet 
P-40 lysis buffer (50 mM Tris [pH 8.0], 100 mM NaCI, 5 mM MgCI2, 
0.5% Nonidet P-40). After 5 rain of incubation on ice, cells were centri- 
fuged for 2 m in at 14,000 rpm at 4 ° C, the supernatant was transferred, 
and SDS was added to a 0.2% final concentration. Cells were extracted 
twice with phenol-chloroform, followed by a chloroform extraction and 
ethanol precipitation. RNA (1-10 t~g) was size-separated on a 1.2% 
denaturing agarose gel (1 M paraformaldehyde) in MOPS buffer (20 
mM MOPS [pH 7.0], 5 mM sodium acetate, 1 mM EDTA), electroblotted 
onto a nylon membrane (GeneScreen, DuPont), and hybridized with 
a c-foe or prodynorphin riboprobe (Ribopmbe system, Promega, Madi- 
son, WI). Hybridization of a cyclophilin cDNA probe (Danielson et al., 
1988) was used as an internal oading control. For animal experiments, 
RNA was prepared as described (Berger and Chirgwin, 1989). Mem- 
branes were visualized with a Phosphorimager (Molecular Dynamics, 
Sunnyvale, CA). 
Immunohistochemistry 
Cell Culture 
Cells were grown on 2-well glass chamber slides (Nunc, Inc., Naper- 
ville, IL) as described above. Prior to staining, cells were washed once 
with PBS and fixed for 15 rain in 4% paraformaldehyde, then washed 
again in PBS until addition of primary antibody. Polyclonal anti-NSE 
(Incstar, Stillwater, MN) and monoclonal anti-GFAP (Sigma) antisera 
were each diluted 1:1000 and incubated for 16 hr at 4°C. The protocol 
used for subsequent steps was according to the Vectastain Elite ABC 
kit (Vector Labs., Burlingame, CA); the antibody complex was devel- 
oped with 3,3'-diaminobenzidine (50 mg per 100 ml of TRIS [pH 7.6]) 
and 0.03% hydrogen peroxide. The GFAP and NSE immunostaining 
in Figure 1 was performed on cells from the same dissection grown 
in parallel slide wells. 
Animals 
Rats were perfused under deep pentobarbital (70 mg/kg) anesthesia 
with 300 ml of 4% paraformaldehyde in PBS. Brains were immersed 
in 30% sucrose for 24 hr, and 40 p,m sections were cut on a freezing 
microtome. Tissue slices were incubated for 16-24 hr at 4°C with 
CREB and phosphoCREB primary antisera (diluted 1:1000; see Ginty 
et al., 1993) and processed with the Vectastain Elite ABC kit. An alter- 
native blocking solution was used for phosphoCREB antiserum (3% 
bovine serum albumin [RIA grade; Sigma], 0.3% Triton X-100, 50 mM 
NaF in PBS). 
Transfection and CAT Assay 
Prodynorphin pro moter constructs in pCAT-Basic vector (Douglass et 
al., 1994) were transfected into primary striatal cultures using Transfec- 
tam (Promega) according to the manufacturer's protocol for serum-free 
transfection. Briefly, 5 p.g of DNA per 25 p.g of Transfectam (ratio = 
1:5) was added to each 35 mm well for 4 hr, at which time cells were 
fed with fresh media. Drugs were applied 24 hr after transfection, and 
cells were harvested 12 hr after the drug treatment. Prior to harvesting, 
cells were washed twice with PBS, scraped into a microfuge tube, and 
spun for 5 min at 14,000 rpm. Cell pellet was resuspended in CAT- 
Tris buffer (250 mM Tris, 1 mM EDTA [pH. 8.0]), and cells were lysed 
by freeze-thaw. Resulting supernatant was stored at 4°C until CAT 
assay was performed. Standard CAT assay was performed according 
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to Promega protocols and applications guide. CAT conversion was 
measured by liquid scintillation counting. Overall transfection effi- 
ciency ranged between 1% and 5%, determined by histochemistry 
following transfection of an RSV-~-galactosidase xpression plasmid. 
While highly reproducible, overall levels of expression from the prody- 
norphin promoter constructs are low. Attempts to decrease the total 
amount of prodynorphin plasmid or to alter the DNA:transfectam ratio 
to permit cotransfection of an internal reference plasmid in the same 
assay reduced expression below reliably detectable limits. Thus, the 
equivalency of transfection efficiency for the 1.6, 1.7, and 2 kb prody- 
norphin constructs was established in CV-1 ceils (Douglass et al., 
1994) prior to transfection of the same plasmids from the same plasmid 
preps into striatal cultures. 
Electrophoretic Mobility Shift Assays 
Electrophoretic mobility shift assays were performed as described for 
primary striatal cultures (Konradi et al., 1994). Oligonucleotides were 
synthesized with partial BamHI sites or a two G overhang and annealed 
in the presence of 20 mM NaPO4, 1 mM EDTA, and 100 mM KCI. The 
overhangs of the double-stranded oligonucleotides were then filled 
in, using Superscript reverse transcriptase (GIBCO), with 32P-labeled 
dCTP. Sequence of oligonucleotides used in electrophoretic mobility 
shift assays were: DynCRE1, 5'-GGGTACCTGGTACGTCACAGA- 
CAT-3'; DynCRE2, 5"GGTAGCCACATCCGTCATCTCGGT-3'; Dyn- 
CRE3, 5'-GGGTGGCTGCTGCGTCAGAGCATG-3' (all prodynorphin 
oligonucleotides were derived from the rat prodynorphin gene); ATF, 
5'-GA TCGCTGACGTCAGGG-3'(Hoeffler et al., 1988; Hai et al., 1989); 
AP-1 (human substance P promoter), 5'-GATCAGCATGAGTCAC- 
TTC-3'(Konradi et al., 1993); AP-1 site (noncanonical; rat prodynorphin 
gene), 5'-GATCGAAGTGACAAACAGCG-3' (Naranjo et al., 1991); 
AP-4 (human proenkephalin gene), 5"GATCGTCAGCTGCAGGG-3' 
(Comb et al., 1988). The double G overhang or partial BamHI site is 
shown in italics, and the core consensus sequences are in bold. The 
CREB and phosphoCREB antisera (Ginty et al., 1993) used in the 
gel-shift analysis immunoprecipitate a single protein of the expected 
molecular weight in extracts from [32P]orthophosphate-labeled striatal 
cultures, indicating specific recognition of CREB protein (Cole et al., 
1994). 
Data Analysis 
For phosphoCREB immunohistochemical nalysis, four to five sec- 
tions from each rat (n = 3 per drug treatment group) were rated for 
phosphoCREB-like immunoreactivity by two independent observers, 
who were blinded to treatment condition, on the following scale: 2, 
strong; 1, modest; and 0, minimal or absent. Mean scores for the two 
raters were then analyzed. The utlility of this ordinal method has been 
previously reported (Cole et al., 1994). Drug treatment effects were 
analyzed by one-factor ANOVA, and Fisher LSD tests were performed 
post-hoc to compare the acute and chronic drug-treated rats with sa- 
line-treated controls. The nonparametric Kruskal-Wallis test was also 
performed. A Mann-Whitney U test was utilized post-hoc to compare 
different drug treatments. All statistical tests were two-tailed. 
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